US Stock MarketDetailed Quotes

Alnylam Pharmaceuticals (ALNY)

Watchlist
  • 291.480
  • -0.550-0.19%
Close May 13 16:00 ET
  • 293.835
  • +2.355+0.81%
Pre 07:57 ET
38.92BMarket Cap73.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals (ALNY) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
AMVUTTRA889.93M76.25%
Net revenues from collaborations82.08M7.03%
GIVLAARI74.39M6.37%
OXLUMO51.32M4.40%
Royalty revenue48.97M4.20%
ONPATTRO20.48M1.75%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States2.07B55.67%
Europe651.09M17.53%
Net revenues from collaborations553.37M14.90%
Rest of world267.93M7.21%
Royalty revenue174.02M4.69%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -